NACLINDNACL Industries Limited
Metals · Agricultural Inputs · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
NACL Industries Limited manufactures and sells agrochemicals in India. The company offers a range of technical products, including myclobutanil, propiconazole, profenofos, tricyclazole, pretilachlors, thiamethoxam, lambda cyhalothrin, bifenthrin, azoxystrobin, tebuconazole, difenoconazole, thifluzamide, bispyribac sodium, clodinafop propargyl, metribuzin, quizalofop ethyl, haloxyfop r methyl, and glufosinate ammonium; and formulations, such as insecticides, fungicides, herbicides, and plant growth regulators and nematicides, as well as pesticides and acaricides. It also provides toll manufacturing services for various multinational companies. The company also exports its products. It markets and sells its products through a network of retail dealers. The company was formerly known as Nagarjuna Agrichem Limited and changed its name to NACL Industries Limited in September 2017. The company was incorporated in 1986 and is based in Hyderabad, India. NACL Industries Limited is a subsidiary of Coromandel International Limited.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on NACLIND — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
Why avoid
- • Overall evidence is weak (AlgoScore 31/100)
- • Revenue growth: -14.5% YoY
- • ROE: 0.7%
- • RSI: 33
- • MACD: bearish
Bull case
- • Profit growth: 36.9% YoY
- • Debt/Equity: 0.46
- • Promoter holding: 74.2%
- • Golden cross setup: SMA50 above SMA200
Bear case
- • Revenue growth: -14.5% YoY
- • ROE: 0.7%
- • RSI: 33
- • MACD: bearish
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • Weak fundamentals — technical strength may not sustain
- • Momentum is fading versus the broader market
- • Revenue growth: -14.5% YoY
- • ROE: 0.7%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹6.86). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.